Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies - Summary of common stock equivalents outstanding were excluded from computation of diluted net loss per share (Details)

v3.22.2.2
Summary of Significant Accounting Policies - Summary of common stock equivalents outstanding were excluded from computation of diluted net loss per share (Details) - shares
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Antidilutive securities     5,247,056  
Common stock warrants        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Antidilutive securities 18,410,000 18,410,000 18,410,000 18,410,000
Earnout Shares        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Antidilutive securities 3,510,405 3,510,405 3,510,405 3,510,405
Unvested RSUs        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Antidilutive securities 5,247,056 0   0